Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 3201 - 3300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 3201 | 26609454 |
US |
2 | |
Stomatitis, Skin ulcer, Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 3202 | 26609455 |
US |
21 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3203 | 26609495 |
US |
26 | |
Dermatitis atopic, Myalgia, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 3204 | 26604019 |
US |
2 | |
Diabetes mellitus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3205 | 26604130 |
BR |
12 | 1 |
Seizure, Dermatitis atopic, Asthma, Allergic eosinophilia, Dyspnoea, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 3206 | 26604338 |
US |
24 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3207 | 26604341 |
US |
20 | 2 |
Dermatitis atopic, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3208 | 26604353 |
US |
51 | 1 |
Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, |
||||
| 3209 | 26604360 |
US |
6 | 1 |
Dermatitis atopic, Rash pruritic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 3210 | 26604419 |
US |
56 | 2 |
Arthralgia, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3211 | 26604420 |
US |
62 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3212 | 26604432 |
US |
17 | 2 |
Dermatitis atopic, Rash erythematous, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 3213 | 26604438 |
US |
21 | 2 |
Eczema eyelids, Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 3214 | 26604542 |
US |
37 | 2 |
Dermatitis atopic, Skin exfoliation, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 3215 | 26604561 |
US |
18 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3216 | 26604562 |
US |
50 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3217 | 26604620 |
US |
55 | 2 |
Injection site pain, Headache, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3218 | 26604622 |
US |
50 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, MELOXICAM, |
||||
| 3219 | 26604625 |
US |
36 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3220 | 26604633 |
US |
21 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3221 | 26604713 |
US |
13 | 2 |
Injection site discomfort, Dermatitis atopic, Product dose omission issue, Injection site pain, |
||||
DUPILUMAB, |
||||
| 3222 | 26604738 |
US |
80 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3223 | 26604775 |
US |
2 | |
Drug hypersensitivity, Vasculitis, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3224 | 26604843 |
US |
46 | 1 |
Dermatitis atopic, Blister, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 3225 | 26604888 |
US |
48 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3226 | 26604897 |
US |
32 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3227 | 26604903 |
US |
63 | 2 |
Sinusitis, Drug hypersensitivity, Urticaria, Pruritus, Swelling, Dermatitis atopic, Rash, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 3228 | 26604980 |
US |
31 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3229 | 26605011 |
US |
1 | |
Dermatitis atopic, Pruritus, Pain, |
||||
DUPILUMAB, |
||||
| 3230 | 26606051 |
US |
17 | 1 |
Ankylosing spondylitis, Arthralgia, Dermatitis atopic, |
||||
SECUKINUMAB, DUPILUMAB, |
||||
| 3231 | 26606588 |
US |
49 | 2 |
Eczema, Dry skin, Skin exfoliation, Dermatitis contact, Dermatitis atopic, Skin discolouration, Rash macular, |
||||
ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 3232 | 26607066 |
US |
||
Sensitivity to weather change, Otitis media, Tympanic membrane perforation, Dermatitis atopic, |
||||
LENIOLISIB, ADAPALENE, ALBUTEROL SULFATE, AMMONIUM LACTATE, BENZOYL PEROXIDE, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, EPINEPHRINE, ESTRADIOL, FLUOXETINE HYDROCHLORIDE, MOMETASONE FUROATE, MOMETASONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, GABAPENTIN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, METHYLPHENIDATE HYDROCHLORIDE, MINOCYCLINE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISONE, RIMEGEPANT SULFATE, ROFLUMILAST, TIOTROPIUM BROMIDE, |
||||
| 3233 | 26607842 |
US |
64 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3234 | 26608012 |
US |
17 | 1 |
Respiratory disorder, Condition aggravated, Skin burning sensation, Eczema, Oral herpes, Illness, Dermatitis atopic, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 3235 | 26608073 |
US |
||
Adrenal insufficiency, Urinary tract infection, Haematuria, Upper respiratory tract infection, Candida infection, Hypopituitarism, Dermatitis atopic, |
||||
LENIOLISIB, ALBUTEROL SULFATE, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, HYDROCORTISONE SODIUM SUCCINATE, PENICILLIN V POTASSIUM, UMECLIDINIUM, |
||||
| 3236 | 26596951 |
CN |
||
Pneumonia, Myocardial necrosis marker increased, Upper respiratory tract infection, Bronchitis, Laryngitis, Urinary tract infection, Gastroenteritis, Paronychia, Cytomegalovirus infection, Hepatic enzyme increased, Dermatitis atopic, Alopecia, |
||||
ECULIZUMAB, |
||||
| 3237 | 26597536 |
US |
||
Dermatitis atopic, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 3238 | 26597773 |
US |
1 | |
Cutaneous T-cell lymphoma, Condition aggravated, Pain, Injury, Anxiety, Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 3239 | 26598174 |
US |
37 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3240 | 26598176 |
US |
2 | 2 |
Eczema, Dermatitis atopic, Rash, Traumatic shock, Drug ineffective, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3241 | 26598190 |
US |
25 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3242 | 26598199 |
US |
12 | 1 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 3243 | 26598201 |
US |
1 | |
Dermatitis atopic, Erythema, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 3244 | 26598292 |
US |
25 | 2 |
Dermatitis, Pruritus, Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 3245 | 26598296 |
US |
49 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3246 | 26598311 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3247 | 26598319 |
US |
60 | 2 |
Headache, Dizziness, Dermatitis atopic, |
||||
DUPILUMAB, MAVACAMTEN, |
||||
| 3248 | 26598331 |
US |
55 | 2 |
Hypotension, Pruritus, Oral discomfort, Rash, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3249 | 26598335 |
US |
2 | |
Dermatitis atopic, Dry eye, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 3250 | 26598345 |
US |
2 | 1 |
Rhinovirus infection, Adenovirus infection, COVID-19, Influenza, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3251 | 26598375 |
US |
15 | 2 |
Dermatitis atopic, Erythema, Hypersensitivity, Swelling face, Skin irritation, Eye swelling, Lip swelling, Dry eye, Feeling cold, |
||||
DUPILUMAB, |
||||
| 3252 | 26598384 |
US |
52 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, DEUCRAVACITINIB, DELGOCITINIB, |
||||
| 3253 | 26598388 |
US |
50 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3254 | 26598389 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3255 | 26598467 |
US |
72 | 1 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 3256 | 26598477 |
US |
24 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Rash, Skin swelling, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3257 | 26598492 |
US |
31 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3258 | 26598503 |
US |
2 | |
Dermatitis allergic, Pruritus, Skin irritation, Swelling, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3259 | 26598546 |
US |
8 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3260 | 26598555 |
US |
58 | 2 |
Vision blurred, Dermatitis atopic, Skin ulcer, Pruritus, |
||||
DUPILUMAB, |
||||
| 3261 | 26598560 |
US |
41 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3262 | 26598573 |
US |
1 | |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 3263 | 26598575 |
US |
32 | 1 |
Skin exfoliation, Pruritus, Dermatitis atopic, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 3264 | 26598577 |
US |
17 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, SOMATROPIN, |
||||
| 3265 | 26598609 |
US |
21 | 1 |
Dermatitis atopic, Inappropriate schedule of product administration, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 3266 | 26598624 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3267 | 26598646 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3268 | 26598648 |
US |
55 | 2 |
Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, |
||||
| 3269 | 26598695 |
US |
2 | |
Dermatitis atopic, Pruritus, Skin haemorrhage, Skin fissures, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3270 | 26598699 |
US |
2 | |
Blister, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3271 | 26598705 |
US |
4 | 1 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 3272 | 26598728 |
US |
20 | 2 |
Injection site swelling, Injection site pruritus, Dermatitis atopic, Rash erythematous, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3273 | 26598741 |
US |
25 | 2 |
Eczema, Dermatitis atopic, Injection site swelling, Device defective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3274 | 26598763 |
US |
68 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3275 | 26598792 |
US |
49 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3276 | 26598795 |
US |
34 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3277 | 26598799 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3278 | 26598802 |
US |
34 | 2 |
Dermatitis atopic, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 3279 | 26598803 |
US |
26 | 2 |
Dermatitis atopic, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 3280 | 26598804 |
US |
9 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3281 | 26598863 |
US |
57 | 1 |
Dermatitis atopic, Product dose omission issue, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3282 | 26598871 |
US |
2 | |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 3283 | 26598882 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3284 | 26598900 |
US |
77 | 1 |
Dermatitis atopic, Rash macular, |
||||
DUPILUMAB, |
||||
| 3285 | 26598909 |
US |
32 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3286 | 26598914 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3287 | 26598933 |
US |
56 | 1 |
Dermatitis atopic, Eye swelling, Alopecia, Pruritus, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3288 | 26598965 |
US |
49 | 2 |
Herpes zoster, Dermatitis atopic, Rash erythematous, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, ETANERCEPT, |
||||
| 3289 | 26598984 |
US |
5 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3290 | 26598989 |
US |
50 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3291 | 26598998 |
US |
2 | |
Dermatitis atopic, Pain, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3292 | 26599027 |
US |
60 | 2 |
Dermatitis atopic, Blister, Off label use, |
||||
DUPILUMAB, |
||||
| 3293 | 26599092 |
US |
59 | 1 |
Dermatitis atopic, Pigmentation disorder, |
||||
DUPILUMAB, |
||||
| 3294 | 26599097 |
US |
2 | |
Dermatitis atopic, Rash, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3295 | 26599146 |
US |
41 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 3296 | 26599149 |
US |
42 | 1 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 3297 | 26599158 |
US |
50 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3298 | 26599160 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 3299 | 26599173 |
US |
6 | 1 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 3300 | 26599182 |
US |
1 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30